These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3. Lanigan MD; Kalman K; Lefievre Y; Pennington MW; Chandy KG; Norton RS Biochemistry; 2002 Oct; 41(40):11963-71. PubMed ID: 12356296 [TBL] [Abstract][Full Text] [Related]
3. Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin. Pennington MW; Lanigan MD; Kalman K; Mahnir VM; Rauer H; McVaugh CT; Behm D; Donaldson D; Chandy KG; Kem WR; Norton RS Biochemistry; 1999 Nov; 38(44):14549-58. PubMed ID: 10545177 [TBL] [Abstract][Full Text] [Related]
4. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. Rauer H; Pennington M; Cahalan M; Chandy KG J Biol Chem; 1999 Jul; 274(31):21885-92. PubMed ID: 10419508 [TBL] [Abstract][Full Text] [Related]
5. Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases. Norton RS; Pennington MW; Wulff H Curr Med Chem; 2004 Dec; 11(23):3041-52. PubMed ID: 15578998 [TBL] [Abstract][Full Text] [Related]